Scientists have issued a literature review of prospective controlled studies comparing the efficacy and safety of two minimally invasive techniques for vertebral augmentation after spine fracture: ...

There are approximately 20 000 new patients diagnosed with myeloma in the United States each year.1 With the availability of better treatments and resultant improved survival, there are currently ...

As many of the subjects participating in the outcomes study underwent multiple sessions, clustering of sessions within subjects was addressed by using mixed models with a random effect for subject for ...

ArthroCare Corp., a developer of state-of-the-art, minimally invasive surgical products, announced in a press release that it has received clearance from the U.S. Food and Drug Administration (FDA) to ...

KALAMAZOO, Mich., April 13 /PRNewswire/ -- Stryker's Interventional Spine business unit today announced the release of its iVAS inflatable vertebral augmentation system, a minimally invasive device ...

CPT copyright 2010 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association. Editor’s Note: This article ...

MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE:MDT) today announced that Noridian Administrative Services, a major Medicare Administrative Contractor providing Medicare insurance coverage in 11 ...

New York, June 06, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vertebral Augmentation Market 2022-2026" - https://www ...

Stryker’s Interventional Spine business unit announced in a press release the introduction of its iVAS inflatable vertebral augmentation system, a minimally invasive device cleared for use in treating ...

ArthroCare, a maker of minimally invasive surgical products, has received FDA clearance for its second-generation Parallax Contour-enhanced vertebral augmentation device, according to a news release.